The MSK-Tracker Study

Summary

This study will co-design and test the feasibility and impact of implementing the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) using an e-PROM (electronic Patient Reported Outcome Measure) delivered via a digital health platform, with innovative embedded components called the MSK-Tracker. The MSK-Tracker uses the MSK-HQ as a foundation to help patients with MSK pain to:

* track the extent to which they are affected by their MSK condition across different aspects of their health,
* prepare appropriately for their clinical encounters, and
* take the right steps to making positive changes to improve their quality of life and manage their condition over the longer-term.

The Study Aims to:

1. Test the ability of the MSK-Tracker to act as an empowerment tool and method of facilitating a person-centred care planning approach in routine MSK clinic consultations.
2. Assess the value of the MSK-Tracker in generating aggregated outputs that inform MSK service improvement.

Study Design This study will use a before and after single Centre design with the comparator between phases 1 and 3 across a range of outcomes. Phase 2 will focus on iterative testing of the MSK-Tracker.

In addition, in Phase 1 and 3 will include qualitative research (site 1 only) using the Experience Based Co-Design (EBCD) methodology to explore the impact of the MSK-Tracker and to inform further improvement and refinement of the tool and its use within the context of an MSK service and clinical practice. The findings from the qualitative research will be triangulated with insights from the aggregated data of patient outcomes to enrich and help make sense of the study findings.

Conditions

• Musculoskeletal Pain

Interventions

OTHER

MSK-Tracker

The intervention is not a treatment, but involves patients and clinicians engaging with the MSK-Tracker software which will facilitate a new care planning approach with the following distinct components: * Pre-clinic preparation. * Clinic dashboard. * Summary action plan. * Personal goal setting. * Follow-up and monitoring.

Sponsors & Collaborators

• Pro-Mapp Limited Company number 10152526

  collaborator INDUSTRY

• Georgina Craig Associates Limited

  collaborator OTHER

• University of Oxford

  collaborator OTHER

• Arthritis Research UK

  collaborator OTHER

• Keele University

  lead OTHER

Principal Investigators

• Jonathan Hill, Dr · Keele University

Study Design

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

SEQUENTIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-07-10

Primary Completion

2019-06-30

Completion

2019-12-30

Countries

• United Kingdom

Study Locations